EE05507B1 - Rosuvastatiini ZD4522) kasutamine heterosgootseperekondliku hperkolesteroleemia raviks - Google Patents

Rosuvastatiini ZD4522) kasutamine heterosgootseperekondliku hperkolesteroleemia raviks

Info

Publication number
EE05507B1
EE05507B1 EEP200300239A EEP200300239A EE05507B1 EE 05507 B1 EE05507 B1 EE 05507B1 EE P200300239 A EEP200300239 A EE P200300239A EE P200300239 A EEP200300239 A EE P200300239A EE 05507 B1 EE05507 B1 EE 05507B1
Authority
EE
Estonia
Prior art keywords
percolesterolemia
heterosgococcal
rosuvastatin
family
treatment
Prior art date
Application number
EEP200300239A
Other languages
English (en)
Estonian (et)
Inventor
Ali@Raza
Howard@Gerard@Hutchinson
Original Assignee
AstraZeneca@AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9903629&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE05507(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by AstraZeneca@AB filed Critical AstraZeneca@AB
Publication of EE200300239A publication Critical patent/EE200300239A/xx
Publication of EE05507B1 publication Critical patent/EE05507B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EEP200300239A 2000-11-22 2001-11-16 Rosuvastatiini ZD4522) kasutamine heterosgootseperekondliku hperkolesteroleemia raviks EE05507B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0028429.9A GB0028429D0 (en) 2000-11-22 2000-11-22 Therapy
PCT/GB2001/005041 WO2002041895A1 (en) 2000-11-22 2001-11-16 Use of rosuvastatin (zd-4522) in the treatment of heterozygous familial hypercholesterolemia

Publications (2)

Publication Number Publication Date
EE200300239A EE200300239A (et) 2003-08-15
EE05507B1 true EE05507B1 (et) 2012-02-15

Family

ID=9903629

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300239A EE05507B1 (et) 2000-11-22 2001-11-16 Rosuvastatiini ZD4522) kasutamine heterosgootseperekondliku hperkolesteroleemia raviks

Country Status (35)

Country Link
US (1) US6858618B2 (bg)
EP (1) EP1339409B1 (bg)
JP (2) JP5062940B2 (bg)
KR (1) KR100815042B1 (bg)
CN (1) CN1268339C (bg)
AR (1) AR031766A1 (bg)
AT (1) ATE394103T1 (bg)
AU (2) AU2002214165B9 (bg)
BG (1) BG66009B1 (bg)
BR (1) BR0115511A (bg)
CA (1) CA2429263C (bg)
CY (1) CY1110428T1 (bg)
CZ (1) CZ301583B6 (bg)
DE (1) DE60133921D1 (bg)
DK (1) DK1339409T3 (bg)
EE (1) EE05507B1 (bg)
ES (1) ES2305118T3 (bg)
GB (1) GB0028429D0 (bg)
HK (1) HK1056691A1 (bg)
HU (1) HUP0301380A3 (bg)
IL (2) IL155919A0 (bg)
IS (1) IS6819A (bg)
MX (1) MXPA03004336A (bg)
MY (1) MY134902A (bg)
NO (1) NO326245B1 (bg)
NZ (1) NZ525754A (bg)
PL (1) PL365386A1 (bg)
PT (1) PT1339409E (bg)
RU (1) RU2294744C2 (bg)
SI (1) SI1339409T1 (bg)
SK (1) SK6212003A3 (bg)
TW (1) TWI238720B (bg)
UA (1) UA75614C2 (bg)
WO (1) WO2002041895A1 (bg)
ZA (1) ZA200303636B (bg)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0003305D0 (en) 2000-02-15 2000-04-05 Zeneca Ltd Pyrimidine derivatives
MXPA05011296A (es) * 2003-04-25 2006-01-24 Gilead Sciences Inc Conjugados de fosfonato inhibidores de la cinasa.
US7452901B2 (en) * 2003-04-25 2008-11-18 Gilead Sciences, Inc. Anti-cancer phosphonate analogs
US20050261237A1 (en) * 2003-04-25 2005-11-24 Boojamra Constantine G Nucleoside phosphonate analogs
US7407965B2 (en) * 2003-04-25 2008-08-05 Gilead Sciences, Inc. Phosphonate analogs for treating metabolic diseases
US20090247488A1 (en) * 2003-04-25 2009-10-01 Carina Cannizzaro Anti-inflammatory phosphonate compounds
ATE490788T1 (de) 2003-04-25 2010-12-15 Gilead Sciences Inc Antivirale phosphonate analoge
US7470724B2 (en) * 2003-04-25 2008-12-30 Gilead Sciences, Inc. Phosphonate compounds having immuno-modulatory activity
WO2005023778A2 (en) * 2003-08-28 2005-03-17 Teva Pharmaceutical Industries Ltd. Process for preparation of rosuvastatin calcium
GB0322552D0 (en) 2003-09-26 2003-10-29 Astrazeneca Uk Ltd Therapeutic treatment
WO2005044308A1 (en) * 2003-10-24 2005-05-19 Gilead Sciences, Inc. Phosphonate analogs of antimetabolites
TW200526596A (en) 2003-11-24 2005-08-16 Teva Pharma Crystalline ammonium salts of rosuvastatin
EP1689723B1 (en) * 2003-12-02 2011-04-27 Teva Pharmaceutical Industries, Ltd. Reference standard for characterization of rosuvastatin
US7851624B2 (en) * 2003-12-24 2010-12-14 Teva Pharamaceutical Industries Ltd. Triol form of rosuvastatin and synthesis of rosuvastatin
US20070179166A1 (en) * 2003-12-24 2007-08-02 Valerie Niddam-Hildesheim Process for preparation of statins with high syn to anti ratio
WO2005115377A1 (en) * 2004-05-26 2005-12-08 Kgk Synergize Inc Functional foods comprising flavonoids and tocotrienols and methods thereof
WO2006017357A1 (en) * 2004-07-13 2006-02-16 Teva Pharmaceutical Industries Ltd. A process for the preparation of rosuvastatin involving a tempo-mediated oxidation step
ES2720618T3 (es) 2004-07-27 2019-07-23 Gilead Sciences Inc Análogos de fosfonato de compuestos de inhibidores de VIH
WO2006091771A2 (en) * 2005-02-22 2006-08-31 Teva Pharmaceutical Industries Ltd. Preparation of rosuvastatin
US20070037979A1 (en) * 2005-02-22 2007-02-15 Valerie Niddam-Hildesheim Preparation of rosuvastatin
US20070167625A1 (en) * 2005-02-22 2007-07-19 Anna Balanov Preparation of rosuvastatin
WO2007022488A2 (en) * 2005-08-16 2007-02-22 Teva Pharmaceutical Industries Ltd. Crystalline rosuvastatin intermediate
US8383614B2 (en) * 2008-01-31 2013-02-26 The Trustees Of The University Of Pennsylvania Hypercholestrolemia and tendinous injuries
US9427437B2 (en) 2008-01-31 2016-08-30 The Trustees Of The University Of Pennsylvania Hypercholesterolemia and tendinous injuries
EP2298745B1 (en) 2008-05-27 2014-09-03 Changzhou Pharmaceutical Factory Preparation method of rosuvastatin calcium and its intermediates
UA103329C2 (ru) 2008-07-08 2013-10-10 Гилиад Сайенсиз, Инк. Соли соединений-ингибиторов вич
RU2018128393A (ru) 2012-09-17 2019-03-14 Мадригал Фармасьютикалз, Инк. Способ синтеза аналогов гормонов щитовидной железы и их полиморфов
US9132117B2 (en) 2013-06-17 2015-09-15 Kgk Synergize, Inc Compositions and methods for glycemic control of subjects with impaired fasting glucose
US10600502B2 (en) 2016-12-20 2020-03-24 Astrazeneca Uk Ltd. Systems and methods for dispensing a statin medication over the counter
PL3661937T3 (pl) 2017-08-01 2021-12-20 Gilead Sciences, Inc. Formy krystaliczne ((s)-((((2r,5r)-5-(6-amino-9h-puryn-9-ylo)-4-fluoro-2,5-dihydrofuran-2-ylo)oksy)metylo)(fenoksy)fosforylo)-l-alaninianu etylu (gs-9131) do leczenia zakażeń wirusowych
MX2021014552A (es) 2019-05-27 2022-02-11 Immatics Us Inc Vectores viricos y uso de los mismos en terapias celulares adoptivas.
DE102020111571A1 (de) 2020-03-11 2021-09-16 Immatics US, Inc. Wpre-mutantenkonstrukte, zusammensetzungen und zugehörige verfahren
US20220008519A1 (en) 2020-07-09 2022-01-13 Costa Rican Social Security Fund / Caja Costarricense de Seguro Social (CCSS) Treatment of severe acute respiratory syndrome-related coronavirus infection with klotho
US20220056411A1 (en) 2020-08-21 2022-02-24 Immatics US, Inc. Methods for isolating cd8+ selected t cells
TW202245775A (zh) * 2021-02-01 2022-12-01 美商瑪德瑞高製藥公司 用於治療肝病症或脂質病症之瑞舒伐他汀（Ｒｏｓｕｖａｓｔａｔｉｎ）和瑞司美替隆（Ｒｅｓｍｅｔｉｒｏｍ）的治療組合

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2648897B2 (ja) * 1991-07-01 1997-09-03 塩野義製薬株式会社 ピリミジン誘導体
US6369103B1 (en) * 1994-01-18 2002-04-09 Bristol-Myers Squibb Company Method for preventing or reducing risk of onset of cardiovascular events employing an HMG CoA reductase inhibitor
GB0001621D0 (en) * 2000-01-26 2000-03-15 Astrazeneca Ab Pharmaceutical compositions
ATE367802T1 (de) * 2000-09-20 2007-08-15 Jagotec Ag Verfahren zur sprühtrocknung von zusammensetzungen enthaltend fenofibrat

Also Published As

Publication number Publication date
EE200300239A (et) 2003-08-15
HUP0301380A3 (en) 2007-03-28
CY1110428T1 (el) 2015-04-29
CZ301583B6 (cs) 2010-04-21
EP1339409A1 (en) 2003-09-03
AU2002214165B9 (en) 2013-07-04
UA75614C2 (uk) 2006-05-15
PL365386A1 (en) 2005-01-10
SI1339409T1 (sl) 2008-08-31
IS6819A (is) 2003-05-19
BG107811A (bg) 2004-03-31
PT1339409E (pt) 2008-07-07
KR100815042B1 (ko) 2008-03-18
GB0028429D0 (en) 2001-01-10
BG66009B1 (bg) 2010-10-29
IL155919A (en) 2009-09-01
ES2305118T3 (es) 2008-11-01
DK1339409T3 (da) 2008-09-08
CN1268339C (zh) 2006-08-09
AU1416502A (en) 2002-06-03
US20040072852A1 (en) 2004-04-15
CA2429263A1 (en) 2002-05-30
HK1056691A1 (en) 2004-02-27
JP2010031047A (ja) 2010-02-12
CA2429263C (en) 2009-03-17
MY134902A (en) 2007-12-31
JP5062940B2 (ja) 2012-10-31
IL155919A0 (en) 2003-12-23
NO20032292L (no) 2003-07-17
WO2002041895A1 (en) 2002-05-30
NZ525754A (en) 2004-10-29
DE60133921D1 (de) 2008-06-19
AR031766A1 (es) 2003-10-01
BR0115511A (pt) 2003-12-30
ATE394103T1 (de) 2008-05-15
MXPA03004336A (es) 2003-08-19
CZ20031406A3 (cs) 2003-09-17
EP1339409B1 (en) 2008-05-07
RU2294744C2 (ru) 2007-03-10
SK6212003A3 (en) 2003-11-04
JP2004522714A (ja) 2004-07-29
TWI238720B (en) 2005-09-01
ZA200303636B (en) 2004-08-12
HUP0301380A2 (hu) 2003-10-28
CN1630520A (zh) 2005-06-22
KR20030048479A (ko) 2003-06-19
AU2002214165B2 (en) 2006-12-14
US6858618B2 (en) 2005-02-22
NO20032292D0 (no) 2003-05-21
NO326245B1 (no) 2008-10-27

Similar Documents

Publication Publication Date Title
EE05507B1 (et) Rosuvastatiini ZD4522) kasutamine heterosgootseperekondliku hperkolesteroleemia raviks
ID30590A (id) Celana sekali pakai jenis-celana pendek
DK1122244T3 (da) Uracilforbindelser og anvendelse deraf
EE05073B1 (et) Retigabiin kasutamiseks neuropaatilise valu ravis
DK1604680T3 (da) Anvendelse af butulinumtoksin ved behandlingen af neuralgisk smerte
EE200300485A (et) Tiohüdantoinid ja nende kasutamine diabeedi raviks
DE50112013D1 (de) Deodorantien und antiperspirantien
NO20024099L (no) Lavdose entecavir-formulering og anvendelse
HK1061212A1 (en) Pyranoindazoles and their use for the treatment ofglaucoma
EE200200571A (et) Hüdroksüfenüülpiperidiin-4-ülideenmetüülbensamiidi derivaadid valu raviks
NO20034159D0 (no) Östrogen-gestagen-kombinasjonspreparat og anvendelse derav
IS6918A (is) Meðferð erfiðra æxla með notkun epóþílon afleiða
AR027945A1 (es) Uso de pramipexol en el tratamiento de transtornos de adiccion
NO20032122D0 (no) Forbedret behandling
IS6966A (is) Cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
IS6967A (is) Ný cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
NO20041968L (no) Anvendelse av cystationin
EE200200577A (et) Kinolinüülpiperidiin-4-ülideenmetüülbensamiidi derivaadid valu raviks
EE200200511A (et) Hüdroksüfenüülpiperasinüülmetüülbensamiidi derivaadid valu raviks
AU9279601A (en) Compounds and methods for use thereof in the treatment of cancer or viral infections
EE200200479A (et) Eksemestaani kasutamine rinnavähi ravis
DK1496918T3 (da) Anvendelse af natriummetaarsenit til behandling af tumorer
ID29706A (id) Artikel kesehatan sekali pakai
ID30381A (id) Penggunaan arilalkanoilpiridazina
ITMI20011820A0 (it) Trattamento di ustioni

Legal Events

Date Code Title Description
HD1A Correction of address
MM4A Lapsed by not paying the annual fees

Effective date: 20161116